[The pathogenesis and therapy of hemostatic disorders in cancer patients].
Barkagan
Z S
ZS
D000925:Anticoagulants / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000097:blood / Q000188:drug therapy / Q000209:etiology*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006487:Hemostasis; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000150:complications*; D013927:Thrombosis / Q000097:blood / Q000188:drug therapy / Q000209:etiology
D000925:Anticoagulants; D005343:Fibrinolytic Agents